Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker
about
Progress of molecular targeted therapies for prostate cancersMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesCarbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array.Determination of carbohydrate structure recognized by prostate-specific F77 monoclonal antibody through expression analysis of glycosyltransferase genes.Shotgun glycomics: a microarray strategy for functional glycomics.The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signalingscFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies.Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.Glycans as targets for therapeutic antitumor antibodies.Specific protein markers for stem cell cross-talk with neighboring cells in the environment.The role of glycans in the development and progression of prostate cancer.Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cellsA spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77.
P2860
Q26823014-01E580E4-AD2F-411D-9625-17403C560C2EQ27011598-9C1BC9E4-42A6-4699-8CF2-1CE34D73D647Q33718563-615484B6-D6C4-48EA-B319-E4461ABC5437Q33718567-21534F15-1330-42BC-A0F5-8CF2AF6FA626Q34781709-3E160D3B-36B9-4DCD-9BBD-BD6413B37764Q35794259-85CC64CD-E38F-4878-A64C-3D64415F3202Q36746278-0CA21AF6-B736-4B3C-B04A-4E3B7DFD63C1Q36778011-82763014-1E2B-4899-A8F0-677B816A2D26Q37425396-F9F180B1-D586-4578-89C6-94BE180DAA4AQ37974938-7824B410-8B28-4EF7-BFEA-3E592FE2010CQ38034815-E11A0598-6CAC-4748-9459-2962394EF9FEQ38175402-680EE4DD-1B10-4A51-89DF-B3E43BAD95B7Q38811520-BB9C1660-6DFE-40A3-807C-8F3D76977877Q41202282-1F7287F9-CFF8-4DF9-9860-63692E8099F9Q48505154-33E344CC-1CEE-4EF9-BABE-A96C0548CAB7
P2860
Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Suppression of human prostate ...... targeting a glycolipid marker
@ast
Suppression of human prostate ...... targeting a glycolipid marker
@en
type
label
Suppression of human prostate ...... targeting a glycolipid marker
@ast
Suppression of human prostate ...... targeting a glycolipid marker
@en
prefLabel
Suppression of human prostate ...... targeting a glycolipid marker
@ast
Suppression of human prostate ...... targeting a glycolipid marker
@en
P2093
P2860
P356
P1476
Suppression of human prostate ...... targeting a glycolipid marker
@en
P2093
Ann M Carroll
Geng Zhang
Hongtao Zhang
Margarita de la Llera-Moya
Mark I Greene
Qiang Wang
Xiaowei Xu
P2860
P304
P356
10.1073/PNAS.0911397107
P407
P577
2009-12-18T00:00:00Z